A3-APO Tetramer

General Information


DRACP ID  DRACP04520

Peptide Name   A3-APO Tetramer

Sequence  XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVRXC,XRPDKPRPYLPRPRPPRPVRXC

Sequence Length  87

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation,Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C430H690N154O82S2

Absent amino acids  AEFGHIMNQSTW

Common amino acids  P

Mass  1158726

Pl  12.58

Basic residues  28

Acidic residues  4

Hydrophobic residues  8

Net charge  24

Boman Index  -37732

Hydrophobicity  -180.46

Aliphatic Index  31.26

Half Life 
  /

Extinction Coefficient cystines  6085

Absorbance 280nm  70.76

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26384569

Title  Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20315

DRACP is developed by Dr.Zheng's team.